The combination of valsartan and ramipril protects against blood vessel injury and lowers blood pressure

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Pharmaceutical Investigation

• Publication date

  2016-03-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40005-016-0241-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results

  2015cited by this paper
• Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients

  2015cited by this paper
• Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria

  2015cited by this paper
• Cell Proliferation Method: Click Chemistry Based on BrdU Coupling for Multiplex Antibody Staining

  2015influential reference
• A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age

  2015cited by this paper
• Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy

  2015cited by this paper
• Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis*

  2015cited by this paper
• Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights

  2015cited by this paper
• Benefit of losartan/hydrochlorothiazide-fixed dose combination treatment for isolated morning hypertension: The MAPPY study

  2015cited by this paper
• Inhibitory effect of a novel naphthoquinone derivative on proliferation of vascular smooth muscle cells through suppression of platelet-derived growth factor receptor β tyrosine kinase.

  2014cited by this paper
• Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats

  2014cited by this paper
• Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study.

  2014cited by this paper
• [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].

  2013cited by this paper
• 5,8-Dimethoxy-2-Nonylamino-Naphthalene-1,4-Dione Inhibits Vascular Smooth Muscle Cell Proliferation by Blocking Autophosphorylation of PDGF-Receptor β

  2013cited by this paper
• Current perspectives on combination therapy in the management of hypertension

  2013cited by this paper
• Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.

  2013cited by this paper
• Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction

  2012cited by this paper
• Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation.

  2011cited by this paper
• Enhanced effect of losartan and rosuvastatin on neointima hyperplasia

  2010cited by this paper
• Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats

  2010cited by this paper
• Synergistic decrease in blood pressure by captopril combined with losartan in spontaneous hypertensive rats

  2009cited by this paper
• Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells

  2006cited by this paper
• Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats.

  2005cited by this paper
• Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan

  2004cited by this paper
• Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation

  2003cited by this paper
• Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys

  2002cited by this paper
• Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury

  2001cited by this paper
• Candesartan Inhibits Carotid Intimal Thickening and Ameliorates Insulin Resistance in Balloon-Injured Diabetic Rats

  2001cited by this paper
• Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats

  1998cited by this paper
• Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells.

  1997cited by this paper
• Ramipril

  1995cited by this paper
• Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries.

  1995cited by this paper
• Potential Importance of Tissue Angiotensin‐Converting Enzyme Inhibition in Preventing Neointima Formation

  1994cited by this paper
• Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries.

  1991cited by this paper
• Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension

  1986cited by this paper
• Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.

  1986cited by this paper

• The combined effects of telmisartan and ramipril on hypertension and cardiovascular injury

  2022cites this paper
• Enhanced oral bioavailability of valsartan in rats using a supersaturable self-microemulsifying drug delivery system with P-glycoprotein inhibitors

  2019cites this paper
• Effects of combination therapy with candesartan and ramipril on hypertension and related complications

  2017cites this paper
• Patient-centered drug delivery and its potential applications for unmet medical needs.

  2017cites this paper
• Rationale and strategies for formulation development of oral fixed dose combination drug products

  2016cites this paper